Protrait

 

Ian Bird, PhD
Professor
Director of Endocrinology Reproductive Physiology Graduate School Program


Reproductive Sciences


Office Address
Meriter Hospital
202 S. Park (Meriter)
Madison, WI, 53715


Administrative Assistant
Cindy Goss
cgoss@wisc.edu
608-417-6314


Education

BSc Birmingham University, Birmingham, U.K.

PhD University of London, Middlesex Hospital Medical School, London U.K.

Fellowship University of Edinburgh, Edinburgh, Scotland

Fellowship UT Southwestern Medical Center at Dallas, Dallas, TX


Honors and Awards

President Elect, Perinatal Research Society, active as President

Secretary Treasurer Elect, Society for Reproductive Investigation

Secretary Treasurer, Society for Reproductive Investigation

Slesinger Award for Excellence in Mentoring Women Faculty (UW-Madison Office of the Secretary of the Faculty Award)


Memberships

Society for Gynecologic Investigation

Perinatal Research Society

Advanced MRI For Uteroplacental Flow, Perfusion, Oxygenation & Inflammation (Shah and Weiben PI, Bird CoI/Alternate PI)

Sponsor(s): NIH/NICHD U01 HD087216

The purpose of this award is to develop new MRI imaging methodologies for the monitoring of normal blood flow, oxygenation and immune cell location in the human placenta in early pregnancy and follow those changes to term.

 


Importance of Endothelial Cell-Cell Communication at the Maternal Fetal Interface test

Sponsor(s): NIH P01 HD038843- (Bird-PI)

This proposal studies cell-cell communication in uterine and umbilical vascular endothelium in pregnancy and the role of kinase activation in regulating those processes in preeclampsia.


Bird Lab publishes in Molecular and Cellular Endocrinology

Several members of the UW Ob-Gyn Division of Reproductive Sciences co-authored an article soon to be published in the journal Molecular and Cellular Endocrinology! Ian Bird, PhD,of the UW Ob-Gyn Division of Reproductive Sciences, is senior author.

The article, examined the relationships between vascular endothelial growth factor, VEGF receptors, and more in affecting pregnancy-adapted programming of the vascular system. Pregnancy diseases like preeclampsia and intrauterine growth restriction are caused by a failure of vascular adaptation, making this research even more important.

You can read the whole article here. Congratulations to Dr. Bird and the entire publication team!

Adenoviral transduction of EGFR into pregnancy-adapted uterine artery endothelial cells remaps growth factor induction of endothelial dysfunction

Luca Clemente; Derek S. Boeldt; Mary A. Grummer; Mayu Morita; Terry K. Morgan; Greg J. Wiepz; Paul J. Bertics; Ian M. Bird


Bird earns grant from Meriter Foundation

Congratulations to Ian Bird, PhD, of the UW Ob-Gyn Division of Reproductive Sciences!

Bird was awarded a grant from the UnityPoint Health-Meriter Foundation Research and Education Committee. The $100,000 grant will support the research project Placenta EGFR transfer to endothelium as the cause of preeclampsia”.

Amazing work, Dr. Bird!


Bird publishes in International Journal of Neonatal Screening

Ian Bird, PhD, of the UW Ob-Gyn Division of Reproductive Sciences, co-authored the article Newborn Screening for Congenital Adrenal Hyperplasia: Review of factors affecting screening accuracy” in the International Journal of Neonatal Screening.

The article discusses limitations to current screening methods for 21-hydroxylase deficiency, and what that means for screening for congenital adrenal hyperplasia:

“Newborn screening for 21-hydroxylase deficiency (21OHD), the most common form of congenital adrenal hyperplasia, has been performed routinely in the United States and other countries for over 20 years. Screening provides the opportunity for early detection and treatment of patients with 21OHD, preventing salt-wasting crisis during the first weeks of life. However, current first-tier screening methodologies lack specificity, leading to a large number of false positive cases, and adequate sensitivity to detect all cases of classic 21OHD that would benefit from treatment. This review summarizes the pathology of 21OHD and also the key stages of fetal hypothalamic-pituitary-adrenal axis development and adrenal steroidogenesis that contribute to limitations in screening accuracy. Factors leading to both false positive and false negative results are highlighted, along with specimen collection best practices used by laboratories in the United States and worldwide. This comprehensive review provides context and insight into the limitations of newborn screening for 21OHD for laboratorians, primary care physicians, and endocrinologists.”

 Read the whole publication here!